Skip to Main Content

Teresa De Marco


Medical Director of Heart Transplantation

Dr. Teresa De Marco is medical director of heart transplantation at UCSF. She cares for patients who have advanced heart failure, undergo heart transplants, and need mechanical circulatory support. She also cares for patients with pulmonary hypertension. She has expertise in all methods of treating and managing advanced heart failure and pulmonary hypertension.

In her research, De Marco evaluates state-of-the-art options for patients with advanced heart failure and pulmonary hypertension. She has served as principal investigator in more than 45 clinical trials (studies using human volunteers to assess promising therapies).

After earning her undergraduate degree from the University of California, Berkeley, De Marco earned her medical degree at the University of California, Irvine. She completed a residency in internal medicine at UCSF, followed by fellowship training in heart failure and cardiovascular disease at UCSF and in heart transplantation at the University of Utah.

De Marco received the UCSF Exceptional Physician Award in 2014 and was inducted into the UCSF Council of Master Clinicians in 2018. She has served on the International Society for Heart and Lung Transplantation's board of directors. She is a member of the scientific leadership council of the Pulmonary Hypertension Association (PHA) and the oversight committee of PHA's accreditation program for Pulmonary Hypertension Care Centers. She also serves on the executive committee for Women in Advanced Heart Failure, Transplantation and Mechanical Circulatory Support Interdisciplinary Network Community. She holds the UCSF R.H. and Jane G. Logan Endowed Chair in Cardiology. She is a fellow of the American College of Cardiology and a fellow of the Heart Failure Society of America.

  • Education

    UC Irvine School of Medicine, MD, 1982

  • Residencies

    UCSF, Internal Medicine, 1985

  • Fellowships

    UCSF, Heart Failure, 1987

    UCSF, Cardiovascular Disease, 1989

    University of Utah, Heart Transplantation, 1989

  • Board Certifications

    Cardiovascular Disease, American Board of Internal Medicine

    Internal Medicine, American Board of Internal Medicine

  • Academic Title


  • Languages


Where I see patients (5)

    My reviews


    Overall Experience
    83 Ratings
    About our process
    Mar 18, 2022
    Outstanding in all respects.
    Feb 14, 2022
    I am extremely happy with my amazing team.
    Oct 20, 2021
    Dr. De Marco is THE best MD I have had at UCSF. I am very fortunate she is my MD!
    Oct 04, 2021
    Jun 11, 2021
    Dr. De Marco and her team are the best! They always respond right away and are on top of all my issues. I am a heart transplant patient.
    Jan 27, 2021
    exceptional doctors!
    Oct 29, 2020
    In my opinion Dr. DeMarco's office and care team are second to none. They have taken fantastic care of me over the years and I could not ask for more. They are truly fantastic and I have all the faith in the world in them that I am getting the best possible care for my condition.
    Sep 14, 2020
    I love Dr DeMarco's she's the smartest doctor I've ever had she was there with me throughout the whole time of waiting for my heart and I appreciate who she is
    Jul 09, 2020
    Dr De Marco never asked me if I had any questions or concerns which I did but because she was always the one talking I never got to address my questions. She talked to the "fellow" about what they would do next like I wasn't even there. This is how it always is when I see her. It's almost an afterthought when she asks me if all that sounds good to me. I feel like I can't talk to her about anything because if she hasn't brought it up it's not worth discussing. I would really like to change doctors but I'm not sure how to go about that.
    Decorative Caduceus

    Pulmonary Hypertension Association Registry

    PAH guideline-recommended diagnostics assessed include chest radiography, echocardiogram, ventilation-perfusion (V/Q) scan, pulmonary function tests, overnight oximetry, and right heart catheterization and identified as either "co...


    Decorative Caduceus

    Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)

    Percentage of Treatment group patients experiencing any device-related Major Adverse Cardiovascular or Neurological Events (MACNE) during the first 90-days after implantation